Top Markets
Coin of the day
Onconic Therapeutics Onconic Therapeutics

Onconic Therapeutics

476060
Clasificación en acciones #21275
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise,... Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Precio por acción
$10.04
Última sincronización: 2026-08-21
Capitalización bursátil
$111.12M
Cambio (1 día)
-1.43%
Cambio (1 año)
-40.73%
País
KR
Comercio Onconic Therapeutics (476060)

Categoría

Ganancias de Onconic Therapeutics (476060)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Onconic Therapeutics, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Onconic Therapeutics desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$-4.02B -
AU
- -
CH